Dealmaking In A Downmarket
New research from Corporate Board Member and Shearman & Sterling asked 250 public company directors to weigh in on Covid-19-fueled activism, mergers and takeovers.
Pulling The Trigger On M&A
M&A lawyers share considerations for pursuing deals and seizing buy and sell opportunities post-Covid.
Proactively Adopting A Poison Pill In Response To The COVID-19 Crisis
Is your board considering whether to implement defensive measures to combat near-term coercive or abusive takeover? Read this.
Creating Shareholder Value Through M&A—And Beyond
Most acquisitions by public companies fail to create long-term value for their shareholders. However, a few companies have demonstrated the ability to consistently generate shareholder value through inorganic investments. What distinguishes these companies is...
How Boards Can Navigate the Overcomplicated and Undervalued M&A Landscape
In a sluggish market, opportunities for synergy abound. But if you don't want your deal to fail in execution—like 80% of M&A—follow these six steps.
M&A, Valuations and Activism: Board Lessons From 2008
The causes are different, but lessons in the context of M&A and activism abound from the 2008 market collapse and the challenging environment that followed.
Corporate Board Member Institute
The leading continuing education program for public company boards.
FEATURED CONTENT
How To Onboard A New Director
Boards must be prepared to onboard new directors and facilitate a process that allows them to hit the ground running.
Guide To Board Assessments
Engaging a useful, annual self-assessment is fundamental to governance excellence. Stakeholders expect it, and disclosure of it evidences a board’s effectiveness and commitment to its role.
Committee Briefings: Top Considerations for 2020
Investor expectations, new disclosure requirements, ESG, current and future trends–your committee agendas are filling up.